EOD Primary Tumor

This input is used for staging

Notes

**Note 1:** When both the Federation Internationale de Gynecologie et d'Obstetrique (FIGO) stage and extension information on the primary tumor are available, use the extension information to assign the code in preference to a statement of FIGO stage. **Note 2:** Peritoneal implants or peritoneal carcinomatosis may also be called seeding, salting, talcum powder appearance, or studding - Extraperitoneal carcinomatosis are coded in EOD Mets **Note 3:** A tumor confined to the peritoneum (code 300) is when there is one pelvic peritoneal tumor, or multiple pelvic peritoneal tumors, without any mention of implants on the specific pelvic/abdominal structures listed in codes 400-750. **Note 4:** Both extension to and/or discontinuous metastasis to any of the following pelvic organs are included in code 450 - Adjacent pelvic (peritoneum) - Bladder - Bladder serosa - Cul de sac (rectouterine pouch) - Ligament(s) (broad, ovarian, round, suspensory) - Mesosalpinx (Meosvarium) - Parametrium - Pelvic wall - Rectosigmoid - Rectum - Sigmoid colon (including sigmoid mesentery) - Ureter (pelvic portion) **Note 5:** If implants are mentioned, determine whether they are in the pelvis or in the abdomen and code appropriately. If the location of the implants is not specified, code 750. **Note 6:** Both extension to and/or discontinuous metastasis to any of the following abdominal organs by way of peritoneal seeding or implants are included in codes 600-750 - Abdominal mesentery - Diaphragm - Gallbladder - Intestine, large (except rectum, rectosigmoid and sigmoid colon) - Kidneys - Omentum (infracolic, NOS) - Pancreas - Pericolic gutter - Peritoneum, NOS - Small intestine - Stomach - Ureters (outside pelvis) **Note 7:** Tumor limited to the peritoneal surface of the liver or splenic capsule is coded 700, regardless of the size (microscopic or macroscopic) - Any **parenchymal** involvement of the liver or spleen is coded in EOD Mets (code 50)

Default

999

NAACCR Item

NAACCR #772
Code Description SS2018 T
000 In situ, intraepithelial, noninvasive, preinvasive Limited to tubal mucosa IS
300 Confined to peritoneum, NOS L
400 Extension to or implants on - Adnexa - Fallopian tube(s) - Ovary(ies) - Uterus, NOS FIGO Stage IIA RE
450 Extension to and/or discontinuous metastasis to pelvic sites (See Note 4) RE
600 Microscopic peritoneal implants or microscopic peritoneal carcinomatosis beyond pelvis (above pelvic rim) (See Note 6) FIGO Stage IIIA D
650 Macroscopic peritoneal implants or macroscopic peritoneal carcinomatosis beyond pelvis (above pelvic rim) (See Note 6) - Less than or equal to 2 cm in diameter FIGO Stage IIIB D
700 Macroscopic peritoneal implants or macroscopic peritoneal carcinomatosis beyond pelvis (above pelvic brim) (See Note 6) - Greater than 2 cm in diameter Extension or implants (microscopic, macroscopic, or unknown) to the peritoneal surface of the liver or splenic capsule - WITHOUT parenchymal involvement of either organ FIGO Stage IIIC D
750 Primary peritoneal carcinoma - WITH confirmed peritoneal metastasis or peritoneal carcinomatosis outside of the pelvis (above pelvic brim) - UNKNOWN if microscopic or macroscopic Peritoneal implants, NOS Further contiguous extension FIGO Stage III [NOS] D
800 No evidence of primary tumor U
999 Unknown; extension not stated Primary tumor cannot be assessed Not documented in medical record Death Certificate Only U
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05.** American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (5) **Introduction to Female Reproductive Organs**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (6) Prat, J., Olawaiye, A.B., Mutch, D.G., et al. **Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017